Induction of leukoderma following allergic contact dermatitis to FreeStyle Libre

2019 ◽  
Vol 81 (6) ◽  
pp. 456-458 ◽  
Author(s):  
Anne Herman ◽  
Laurence Montjoye ◽  
Liliane Marot ◽  
Marie Baeck

2020 ◽  
Vol 83 (2) ◽  
pp. 154-157
Author(s):  
Catarina S. Queirós ◽  
Maria I. Alexandre ◽  
Pedro M. Garrido ◽  
Teresa E. Correia ◽  
Paulo L. Filipe




2018 ◽  
Vol 79 (5) ◽  
pp. 320-321 ◽  
Author(s):  
Monica Corazza ◽  
Valeria Scuderi ◽  
Dario Musmeci ◽  
Caterina Foti ◽  
Paolo Romita ◽  
...  


2020 ◽  
Vol 78 (4) ◽  
pp. 381-384
Author(s):  
C. S. Queirós ◽  
M. I. Alexandre ◽  
P. M. Garrido ◽  
L. Soares de Almeida ◽  
T. Correia ◽  
...  

In the past few years, the glucose sensor FreeStyle Libre® has been associated with several cases of allergic contact dermatitis. The allergen responsible for most of these cases is isobornyl acrylate, a substance present within the sensor that migrates through the adhesive, thereby reaching the skin. Acquired leukoderma, which may occur in an area previously affected by allergic contact dermatitis, has been described in several medical devices with adhesives. However, until the present, only one case of leukoderma induced by allergic contact dermatitis to FreeStyle Libre® has been described. We report the case of a 41-year-old woman with diabetes mellitus type 1, who developed leukoderma in association with allergic contact dermatitis to this glucose sensor.



2019 ◽  
Vol 14 (3) ◽  
pp. 582-585 ◽  
Author(s):  
Stefanie Kamann ◽  
Lutz Heinemann ◽  
Eva Oppel

Background: Continuous glucose monitoring (CGM) systems replace more and more capillary self-monitoring of blood glucose by patients with diabetes. However, at least a subset of patients experience adverse skin reactions such as severe allergic contact dermatitis (ACD) after prolonged usage of CGM systems. A major allergen isobornyl acrylate (IBOA) has been identified recently. Objectives: After developing an ACD, patients have difficulties in continuing the usage of their CGM system (and also of, eg, certain patch pumps). Most of such patients look for possibilities to continue the usage of, eg, a CGM system that requires intermittent scanning (iscCGM, Freestyle Libre). Patients and Methods: Eight patients with a known ACD were supplied with different hydrocolloid-based plasters ( n = 5 with Hansaplast blister plaster, n = 2 with Cutimed Hydro B from BSN, and n = 1 with Stomahesive baseplate from Convatec). They attached these plasters to their skin underneath their iscCGM system. Results: All patients were able to continue the usage of this iscCGM system when using such plasters. Conclusion: Patients with ACD benefit from the usage of such plasters; however, some limitations have to be acknowledged.





1977 ◽  
Vol 113 (8) ◽  
pp. 1058-1061 ◽  
Author(s):  
D. K. Goette






Sign in / Sign up

Export Citation Format

Share Document